Viewing Study NCT05957367


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2025-12-25 @ 10:37 PM
Study NCT ID: NCT05957367
Status: RECRUITING
Last Update Posted: 2025-10-22
First Post: 2023-07-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Sponsor: Deciphera Pharmaceuticals, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module